Voloridge Investment Management, LLC Aprea Therapeutics, Inc. Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.43 - $5.63 $521,925 - $856,688
-152,165 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$4.05 - $5.5 $615,733 - $836,181
-152,033 Reduced 49.98%
152,165 $743,000
Q1 2021

May 17, 2021
BUY
$4.73 - $8.15 $1.44 Million - $2.48 Million
304,198 New
304,198 $1.55 Million

Others Institutions Holding APRE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Aprea Therapeutics, Inc.

APRE Quotes by TradingView
  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email